# Phase 8 — Multi-Agent Analyst Desk

**Ticker:** PATH
**As-of date:** 2026-08-12
**Generated:** 2026-08-13T03:35:00Z
**Upstream phases cited:** phase-1 through phase-7c (full packed context)

## Runtime note

The five named `subagent_type` values specified by this phase
(`accumulation-hunter`, `contrarian-scanner`, `sweep-tracker`,
`earnings-scout`, `risk-monitor`) were **not registered in this session's
agent runtime** (`Agent type '<name>' not found. Available agents: claude,
claude-code-guide, Explore, general-purpose, Plan, statusline-setup`). Per
this phase's own instruction ("If an agent type is unavailable... write a
`MISSING:` line... and proceed. Do NOT abort the phase"), all five were
missing — rather than aborting the phase, all five were re-launched as
`general-purpose` agents carrying the identical role-specific prompt (the
same packed phases 1–7c context, the same per-agent template, the same
"You are `<ROLE>`..." framing). This preserves the intended five independent
analytical lenses even though the specialized subagent presets weren't
available on this machine.

## Summary

**4 of 5 agents landed NEUTRAL, 1 landed SHORT — zero LONG verdicts.**
Average conviction 2.2/5. This is a clean, convergent signal: even though
the flow-only phases (2 dark pool, 4 dealer structure, 5 historical) leaned
mildly bullish on the multi-week structural read, every single agent that
also had phase-7b's fundamental VETO and phase-7c's sentiment CAUTION in
context declined to go LONG. The one dissent (contrarian-scanner) pushed
further to an outright SHORT, reasoning that the rally shows no
short-covering fuel (short interest rose through it) and is now decelerating
into a stacked veto — a fade candidate, not a momentum long. All five agents
independently converged on the same support/resistance levels sourced from
phase-2/phase-3 ($14.86–14.87 / $13.89–13.93 support, $16.00 resistance),
confirming those levels are robust across analytical lenses, not an artifact
of one phase's framing.

## Agent verdicts table

| Agent (role-prompted) | bias | conviction | horizon | one_line_take |
|---|---|---|---|---|
| accumulation-hunter | NEUTRAL | 2 | 1-4w | Real 30-day quiet buying, but decelerating into an insider/earnings veto — respect the footprint, don't chase it here, watch-only until post-earnings. |
| contrarian-scanner | **SHORT** | 3 | 1-4w | Crowded long tape, no squeeze fuel behind it, earnings-miss/insider VETO stacked underneath — fade the rally toward $13.89-13.93, size small given long-gamma chop risk. |
| sweep-tracker | NEUTRAL | 2 | 1-5d | No sweep signal here today — flow's flat and mixed, the LEAP put chain is offsetting, stand aside and wait for a real directional print. |
| earnings-scout | NEUTRAL | 2 | 1-4w | Insider -100 and a broken beat-streak argue caution into 9/3, but flow shows no one's actually positioned for it — sit out, don't chase either side pre-print. |
| risk-monitor | NEUTRAL | 2 | 1-4w | No concurrent-position risk, but TRANSITIONAL regime, adverse sector rotation-delta, and pre-earnings gap risk stack atop 7b/7c gates — defined-risk sizing only. |

## Per-agent details

### accumulation-hunter
```
VERDICT
- bias: NEUTRAL
- conviction: 2
- horizon: 1-4w
- key_levels:
    support: $14.86-14.87 (support 1); deeper $13.89-13.93 (prior base, support 2)
    resistance: $15.19-15.54 (near-spot pivot/congestion); $16.00 (call wall)
    invalidation: daily close below $13.89 (prior base breaks, erases the entire
      30-session accumulation footprint) OR insider MSPR/earnings-trend flips to
      a third contradiction before 9/3 print
- top_signal: Phase 5's 30-session OI-build (+318,061 contracts, 29 of 30
  sessions positive, zero gamma-regime flips) alongside phase-2's ex-mega
  large-tier buy_ratio 0.678 (2.96% of float bought) is real, structural quiet
  accumulation — but today is the smallest OI-build day of that streak, and
  the signal-backtest for dark_pool_accumulation fired zero times historically
  (no empirical edge to size against).
- top_risk: Phase 7b's genuine VETO (EPS miss -7.86% breaking a beat streak +
  insider MSPR at the -100 floor in the most recent month, both ahead of the
  9/3 print) plus phase-7c's finding that short interest is rising (not
  covering) through the rally and PATH sat out a peer's beat-driven rally —
  the accumulation footprint may be stale, and smart money looks more cautious
  into earnings than the dark-pool prints alone suggest.
```

### contrarian-scanner (dissent)
```
VERDICT
- bias: SHORT
- conviction: 3
- horizon: 1-4w
- key_levels:
    support: $14.86-14.87 (phase-2 support 1); breakdown target $13.89-13.93
      (support 2, prior base)
    resistance: $16.00 (phase-3 near-term call wall) / $15.19-15.54 (phase-2
      pivot congestion, contains spot)
    invalidation: daily close above $16.50 (next call-wall rung) on renewed
      OI-build reacceleration
- top_signal: Phase-7c — short interest rose (126.25M->138.92M shares)
  THROUGH the +32% rally rather than covering it, meaning the move wasn't
  short-squeeze fuel and shorts are still pressing into a crowded long tape
  now showing phase-5's decelerating OI-build (today = smallest add of the
  29-day streak) plus RSI(14)=70.94 overbought.
- top_risk: Dealer book is structurally long-gamma the entire rally (phase-4,
  zero_gamma $8.64, zero flips in 30 sessions) which suppresses realized vol
  and mean-reverts both ways — a fade can grind sideways in the $15.19-15.54
  pivot rather than break down, and 31.10% short interest (13x peer GTLB)
  leaves squeeze risk on any positive catalyst before 9/3 earnings.
```

### sweep-tracker
```
VERDICT
- bias: NEUTRAL
- conviction: 2
- horizon: 1-5d
- key_levels:
    support: $14.86-14.87 (dark-pool support 1); deeper $13.89-13.93
    resistance: $16.00 (call wall) then $16.50/$17.00
    invalidation: daily close below $13.89 (loses lower dark-pool support) or
      a fresh aggressive ask-side sweep cluster >$1M reigniting the
      2028-12-15 put chain in one direction
- top_signal: Phase 1's dominant flow theme (2028-12-15 $10/$12 put LEAP
  chain, $8.47M cumulative sweep premium) tags dominant_direction="mixed"
  with near-identical ask/bid sizing (1,148 vs 1,150 contracts) — no
  aggressive directional sweep conviction exists in the tape today.
- top_risk: Today's OI action was a broad call unwind (calls -4,048 vs puts
  -982 contracts, phase-3) coinciding with the -2.93% price drop — that's
  de-risking, not a sweep-driven setup I can chase, and phase-7b's
  earnings-miss/insider VETO removes any case for forcing a directional
  sweep trade into it.
```

### earnings-scout
```
VERDICT
- bias: NEUTRAL
- conviction: 2
- horizon: 1-4w
- key_levels:
    support: $14.86-14.87 (5d DP support-1); deeper $13.89-13.93 (support-2,
      pre-rally base)
    resistance: $16.00 (nearest call wall / largest near-term OI resistance)
    invalidation: daily close below $13.89 breaks the accumulation thesis
      pre-print; daily close above $16.50 negates the bearish fundamental lean
- top_signal: Phase 7b's fundamental veto lands directly ahead of the print —
  EPS missed -7.86% last quarter (breaking a 3-quarter beat streak) and
  insider MSPR sat at the -100 floor in the most recent available month
  (July 2026), yet PATH is absent from earnings-play top-10 (IV rank 63.16
  doesn't clear the extremity bar) and the 2028 LEAP put chain ($8.47M) reads
  mixed/hedge-not-directional — no options-flow confirmation of the
  fundamental deterioration.
- top_risk: IV term structure shows a genuine kink at the 2026-09-04 expiry
  (avg IV 146.4% vs 63.8% the week prior) confirming real event-vol pricing,
  but with 31.10% short interest still rising through the rally and dealers
  long-gamma into the print, a beat could trigger a violent mechanical
  squeeze that overwhelms the bearish fundamental setup.
```
(Note: earnings-scout ran 5 additional `uw` tool calls to independently
verify IV pricing specifically into the earnings date — the 2026-09-04
expiry read is new information not in the packed phase-1–7c context, and
should be cross-checked by phase-9/10 against phase-4's IV-term-structure
contamination note, since 2026-09-04 was one of the two dates phase-4 flagged
as containing deep-ITM parity artifacts.)

### risk-monitor
```
VERDICT
- bias: NEUTRAL
- conviction: 2
- horizon: 1-4w
- key_levels:
    support: $14.86-14.87 (phase-2 dark-pool mid support, -2.6%); harder
      floor $13.89-13.93 (-8.9%)
    resistance: $16.00 (phase-3 near-term call wall, +5.06%)
    invalidation: daily close below $13.80 (phase-4 today's zero-gamma level)
      flipping dealer regime negative and confirming trend break, OR any
      position still directionally exposed into the 2026-09-03 postmarket
      earnings print (IV-crush/gap risk, 22 days out)
- top_signal: Phase 6's two UW tools diverge — Technology sector-flow LEVEL
  is bullish (+$3.92B, 5/5-day inflow persistence) but the narrower
  rotation-delta shows Technology losing money today (-$34.0M, alongside
  Communication Services and Consumer Cyclical, while Industrials/Healthcare/
  Financial Services gain), and PATH's own peers PANW/PLTR sat on the
  bearish side of today's single-name leaderboard — near-term correlated
  sector risk skews adverse even though the structural sector backdrop is
  fine.
- top_risk: Three independent caution sources now converge on the same
  setup — phase-6 market-regime (TRANSITIONAL, explicit half-size/
  defined-risk-only guidance), phase-7b's fundamental VETO (EPS miss +
  insider MSPR at -100 heading into 9/3 earnings), and phase-7c's sentiment
  CAUTION (rising 31.10% short interest not covering) — while the earnings
  date sits just 22 days out and 31.10% short float raises binary gap-risk
  in either direction on that print.
```
Confirmed explicitly: **no concurrent-position correlation risk** — PATH is
the only blueprint dated 2026-08-12.

## Disagreements

**contrarian-scanner (SHORT, conviction 3) vs. the 4-agent NEUTRAL
majority.** Its `top_signal` (short interest rose through the rally, not a
short-covering move) is a legitimate, independently-sourced read from
phase-7c that the other four agents also had in context but weighted less
heavily. Per this phase's own interpretation heuristic ("4-of-5 with one
strong dissent — read the dissent's top_signal carefully, often it's the
missing piece"): this dissent is not noise — it correctly identifies that
the bullish flow-phase read (phases 2/4/5) lacks the one confirming leg
(short covering) that would make "quiet accumulation" the most likely
explanation for the rally. The majority's NEUTRAL stance already prices in
this risk (all four cite the VETO/CAUTION stack and short-interest trend in
their own `top_risk` fields) without going so far as to flip outright short.

## Tool errors

- All five `subagent_type` values from this phase's spec
  (`accumulation-hunter`, `contrarian-scanner`, `sweep-tracker`,
  `earnings-scout`, `risk-monitor`) errored with "Agent type not found" on
  first launch — see Runtime note above. Recovered by relaunching as
  `general-purpose` with identical role-prompts; phase not aborted.

## Verdict for downstream phases

- **Plurality bias:** NEUTRAL, 4 of 5 (80%); 1 SHORT dissent (contrarian-
  scanner). **Zero LONG verdicts** — notable given phases 2/4/5 individually
  leaned mildly bullish before the 7b/7c gates were applied.
- **Average conviction:** 2.2/5 (2, 3, 2, 2, 2)
- **Three highest-quality signals across all agents:**
  1. Short interest rose through the +32% rally rather than covering it
     (contrarian-scanner, sourced from phase-7c) — the single strongest
     argument against reading the rally as pure institutional accumulation.
  2. Three independent caution sources (market-regime TRANSITIONAL +
     phase-7b VETO + phase-7c CAUTION) now converge on the same setup
     (risk-monitor) — a compounding, not merely additive, risk picture.
  3. No options-flow confirmation of the fundamental deterioration —
     the 2028 LEAP put chain reads mixed/hedge, not a directional bet
     pricing in the earnings-miss/insider-selling risk (earnings-scout) —
     meaning if the fundamental case is right, the options market hasn't
     caught up to it yet.
- **Open questions surfaced by agents:**
  1. Is the 2026-09-04 IV kink (avg IV 146.4%, earnings-scout's fresh pull)
     genuine event-vol pricing into the 9/3 print, or another instance of
     the deep-ITM parity-artifact contamination phase-4 already flagged at
     that same expiry? Needs reconciliation before phase-9 sizes an
     earnings-adjacent options structure off it.
  2. Does the dealer long-gamma regime (risk-monitor, contrarian-scanner)
     mean a short thesis is more likely to chop sideways in the $15.19–15.54
     pivot than to break down cleanly toward $13.89–13.93, even if the
     fundamental/sentiment case is right?
  3. All five agents converged on $14.86–14.87 / $13.89–13.93 as support and
     $16.00 as resistance — phase-9/10 should treat these as
     well-corroborated, cross-lens levels rather than single-phase artifacts.
